*Note update to eligibility criteria regarding pursuit of ‘logical next steps’ from an Innovation or CBCF grant.

These grants are intended to support the next phase following a productive CCS Innovation Grant or CBCF research grant, with the goal of working towards or achieving a significant impact on cancer.

Applicants are required to articulate significant achievements from the original Innovation/CBCF Grant (i.e., significant new knowledge, publications, intellectual property, technology development, or relevant endpoints) and clearly describe and justify the progression to the new research proposed. In other words, the original grant and the i2I proposal must be linked by their overarching goal or objective. Applicants must also describe the potential for impact of the proposed project on cancer.

Budgets awarded may be up to $150,000 per year for up to 3 years, to a maximum of $450,000 per grant.

It is anticipated that approximately 15 grants will be awarded in this competition.

Please note that only investigators with a funded Innovation or CBCF research grant with a project end date between January 1, 2017 and April 30, 2020 are eligible for this program.

Full application deadline: October 15, 2019

Results announcement: April 2020

Anticipated start date: May 1, 2020

Please review the full Program Description on our website.

Innovation Grants support the highest quality creative problem solving in cancer research. The goal of the Innovation program is to support the development and testing of transformative, paradigm-shifting concepts and approaches to address problems in cancer research, enhance our understanding of cancer, and generate novel approaches to confront the challenges we face in defeating cancer.

Budgets awarded may be up to $100,000 per year and a maximum of $200,000 per grant.

It is anticipated that approximately 30 grants will be awarded in this competition.

Please note the following:

• ·         Innovation Grants are offered once per year. The timeline below is anticipated to be consistent going forward.
• ·         This competition consists of a full application only, abstract registration is not required
• ·         There must be no (0%) overlap with any pending or held grant applications (i.e. 100% unique aims are required - conceptual overlap is acceptable but must be described by the applicant)

Special funding calls within the Innovation Grant competition envelope:

• Applications relevant to breast cancer research are encouraged
• Applications relevant to skin cancer are encouraged
• As a result of a generous donation, funding for one application with a focus on early detection, diagnosis, and/or treatment of malignant mixed Müllerian tumours (MMMT) is available
• Additional funds may be available from the Lotte and John Hecht Memorial Foundation to support innovative projects focused on the application of complementary and alternative approaches in cancer treatment and control

Full application deadline: October 15, 2019

Results announcement: April, 2020

Anticipated start date: May 1, 2020

Please review the full Program Description on our website.

In 2019, the Health Research Foundation (HRF) of Innovative Medicines Canada will award two (2) research Fellowships in the area of Artificial Intelligence (AI) Health Research in its impact on health care in Canada. One of the Fellowships will focus on AI’s impact on health system sustainability, while the second Fellowship will focus on AI’s impact on patient outcomes.

The objectives of these HRF Fellowships is to support outstanding MD and/or PhD researchers to become our future scientists and healthcare leaders with the tools to contribute to the innovative health care system of tomorrow, and to facilitate collaboration, teamwork, and trust between academic research centers and the pharmaceutical industry to find better ways to transfer knowledge from research to the health system.

Each fellowship will have an award of $100,000 and is available to one person per fellowship. The Fellowships are awarded with the expectation that the recipient will continue to demonstrate excellence in their field of work.

The deadline for the final application package is September 27, 2019.

The 2019 HRF Guidelines and Application Form are attached and can also be found on the Health Research Foundation’s website at: http://hrf-frs.com/en/programs/hrf-artificial-intelligence-health-research-fellowships

The Ship Time program allows those holding an NSERC Discovery Grant (DG) to apply for additional funds to access vessels in support of their research programs.

In 2017, Canada’s transportation sector accounted for 24% of national GHG emissions.  The increased adoption of zero-emission vehicles (ZEVs) is key to decarbonizing our transportation sector and transitioning to a low-carbon future. The Government of Canada established the EVID Program as part of Budget 2016’s investment in green infrastructure.  Budget 2017 allocated up to $30M to the EVID Program from April 1, 2018 to March 31, 2022 to continue to support demonstrations of next-generation and innovative electric vehicle (EV) charging infrastructure that address technical and non-technical barriers to the installation, operation and management of EV charging technologies. 

This request for proposals (RFP) will allocate up to $15M towards non-repayable contributions for both EV charging and hydrogen (H2) refuelling infrastructure demonstration projects.

Projects must be likely to advance the field of cancer diagnostic, prognostic or predictive testing. Collaborations between Ontario institutions, including the trans-institutional use of core resources, are encouraged as is leveraging of existing collaborative clinical trials networks. It is expected that most proposals will make use of primary human cancer samples.

Examples of the types of projects OMPRN seeks to fund include:

• Novel approaches to making definitive pathological cancer diagnoses under challenging circumstances such as small tissue samples or difficult-to-recognize cancer types;
• Incorporation of molecular data in the pathological classification of tumours;
• Identification or validation of prognostic or predictive cancer biomarkers, including in the context of drug discovery or clinical trials.

Kidney Health Research Grants provide financial support to medical researchers to assist in defraying the operating costs of research, which may include the purchase of materials, supplies and equipment and the payment of laboratory assistants.

Grants are available for one, two or three years, commencing July 1, for up to $60,000 per year. The research must be carried out in Canada.

Applications to the Fiscal Year 2019 (FY19) Defense Medical Research and Development Program (DMRDP) Joint Program Committee 8/Clinical and Rehabilitative Medicine Research Program (JPC-8/CRMRP), Restoring Warfighters with Neuromusculoskeletal Injuries Research Award (RESTORE) are being solicited for the Defense Health Agency (DHA) J9, Research and Development Directorate, by the U.S. Army Medical Research Acquisition Activity (USAMRAA) using delegated authority provided by United States Code, Title 10, Section 2358 (10 USC 2358). As directed by the Office of the Assistant Secretary of Defense for Health Affairs (OASD[HA]), the DHA manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The Congressionally Directed Medical Research Programs (CDMRP) provides DMRDP execution management support for DHP core research program areas, including JPC-8/CRMRP. This Program Announcement/ Funding Opportunity and subsequent awards will be managed and executed by CDMRP with strategic oversight from JPC-8/CRMRP.

The FY19 Program Announcement and General Application Instructions for the following award mechanism are posted on the Grants.gov website.

https://cdmrp.army.mil/funding/pa/FY19-JPC8-RESTORE.pdf

Restoring Warfighters with Neuromusculoskeletal Injuries Research Award (RESTORE) – Preproposal due September 3, 2019

For All Research Levels:  Investigators at or above the level of Assistance Professor (or equivalent).

• ·         Supports research in the areas of optimal management, treatment, and restoration following Service-related Neuromusculoskeletal injury, including acute combat/non-combat injury, repetitive overuse injury, limb loss, and limb trauma.
• ·         Proposed projects will accelerate progress toward returning Warfighters to combat readiness following Neuromusculoskeletal injury.
• ·         Collaboration among academia, industry, the DoD, and the Department of Veterans Affairs is encouraged.
• ·         Applications submitted to the RESTORE must address one or more of the Focus Areas.
• ·         Fundamental basic research is not allowed.
• ·         Preproposal submission is required; application submission is by invitation only.

The RESTORE offers three Research Levels:

Research Level 1:

• ·         Maximum funding of $500,000 for total costs (direct costs plus indirect costs).
• ·         Maximum period of performance is 3 years.

Research Level 2:

• ·         Maximum funding of $1,500,000 for total costs (direct costs plus indirect costs).
• ·         Maximum period of period 4 years.

Research Level 3:

• ·         Maximum funding of $3,000,000 for total costs (direct costs plus indirect costs).
• ·         Maximum period of performance is 4 years.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the PHTBIRP or other CDMRP-administered and supported programs, please visit the CDMRP website (https://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk

301-682-5507 
help@eBrap.org

CIHR’s Health Research Training Strategy aims to equip research trainees so that they emerge from their training as scientific, professional, or organizational leaders within and beyond the health research enterprise. Generating Research Leaders of tomorrow is a key objective for CIHR.

Fellowships provide support for highly qualified applicants in all areas of health research at the post-PhD degree or post-health professional degree stages to add to their experience by engaging in health research either in Canada or abroad.